Reaction Details |
| Report a problem with these data |
Target | Beta-3 adrenergic receptor |
---|
Ligand | BDBM50148515 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_39051 |
---|
Ki | 10000±n/a nM |
---|
Citation | Washburn, WN; Sun, CQ; Bisacchi, G; Wu, G; Cheng, PT; Sher, PM; Ryono, D; Gavai, AV; Poss, K; Girotra, RN; McCann, PJ; Mikkilineni, AB; Dejneka, TC; Wang, TC; Merchant, Z; Morella, M; Arbeeny, CM; Harper, TW; Slusarchyk, DA; Skwish, S; Russell, AD; Allen, GT; Tesfamariam, B; Frohlich, BH; Abboa-Offei, BE; Cap, M; Waldron, TL; George, RJ; Young, D; Dickinson, KE; Seymour, AA BMS-201620: a selective beta 3 agonist. Bioorg Med Chem Lett14:3525-9 (2004) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Beta-3 adrenergic receptor |
---|
Name: | Beta-3 adrenergic receptor |
Synonyms: | ADRB3 | ADRB3R | ADRB3_HUMAN | B3AR | Beta-2 adrenergic receptor and beta-3 adrenergic receptor | Beta-3 adrenoceptor | Beta-3 adrenoreceptor | adrenergic Beta3 |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 43534.88 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 408 |
Sequence: | MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIV
AIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLC
VTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRV
GADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRG
ELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGT
FTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLL
CRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS
|
|
|
BDBM50148515 |
---|
n/a |
---|
Name | BDBM50148515 |
Synonyms: | (S)-N-((R)-2-Hydroxy-5-{1-hydroxy-2-[(S)-1-(4-methoxy-phenyl)-2-oxo-2-piperidin-1-yl-ethylamino]-ethyl}-phenyl)-methanesulfonamide | CHEMBL119210 |
Type | Small organic molecule |
Emp. Form. | C23H31N3O6S |
Mol. Mass. | 477.574 |
SMILES | COc1ccc(cc1)[C@H](NC[C@H](O)c1ccc(O)c(NS(C)(=O)=O)c1)C(=O)N1CCCCC1 |
Structure |
|